Shenzhen Chipscreen Biosciences, which plans to list on China's red-hot new tech board, said its newly issued shares were almost 3,000-times oversubscribed among retail investors, despite an eye-popping offer pricing of 468-times earnings.
from Reuters: Technology News https://ift.tt/2YAnwKn
0 comments:
Post a Comment